Evaluation of OPC-17116 against important pathogens that cause respiratory tract infections.

The antibacterial activity of OPC-17116, a new fluoroquinolone antibacterial agent, against important pathogens that cause respiratory tract infections was evaluated in vitro and in vivo and compared with those of ciprofloxacin, ofloxacin, and norfloxacin. The pharmacokinetic profiles of OPC-17116 w...

Popoln opis

Bibliografske podrobnosti

izdano v:	Antimicrob Agents Chemother
Principais autores:	Wakebe, H, Imada, T, Yoneda, H, Mukai, F, Ohguro, K, Ohmori, K, Tamaoka, H, Yabuuchi, Y
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1994
Teme:	Research Article
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284741/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7840567/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.10.2340
Oznake:	Označite Brez oznak, prvi označite!